OptoCeutics (a combination of Optical & Pharmaceutics) was established in 2018 as a university spin-out based on a patent from collaborative research at Danish Technical University (DTU) and University of California Berkeley (UCB).
We are advancing digital therapeutics solutions to neurological and psychiatric disorders such as
Here’s the inside story of our passionate co-founder and CEO, Ngoc Mai Nguyen, and her entrepreneurial journey with OptoCeutics.
Watch this video to find how a group of scholars developed and patented a potential solution to neurodegenerative disease in record time.
OptoCeutics solutions are developed to meet these three goals:
We engage in a dialogue with patients, their families and practitioners early in the development to be aligned with their needs and preferences.
We develop solutions that are comfortable, safe to use, and completely non-invasive.
The solution is to be used in the comfort of your own home. It is convenient and easily implementable in the everyday life.
Mai Nguyen
CEO
Marcus S. Carstensen
CTO
Jakob A. Hildebrandt
Business Development & Marketing
Gustavo Miguel Feijóo
Lead Electrical Engineer
Jeppe Sloth-Olsen
Medical Design Engineer
Anders Bækhøj Larsen
Lead Developer
Henrik Enggaard Hansen
Firmware Engineer
Kasper Pihl
Product Manager
Chris Cobarruvias
Int’l Business Development
Marco Taranta
Digital Marketing Coordinator
Luna Skytte
Scientific Project Manager
Mark Alexander Henney
Eye-tracking Software Developer
Christopher Ravn Boe Jensen
Software & AI Developer
Jonas L. Lyngfos
Regulatory Affairs and Health Care Compliance
Asger Laurtis
Software Development Assistant
Mikkel Danielsen
Software Development Assistant
Martin Thorning-Schmidt
Photonics Researcher
Tjalfe Egholm Rude
Electrical Engineer Assistant
Marc Johannes van der Zwan
UX Design Engineer
Manuela Gajardo Bohme
Clinical & User Involvement Strategist
Bianca Laura Hansen
EEG Assistant
Sign-up to our newsletter and receive new information about our developments, clinical trials and more.
